Latest stories on KPTI
Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026 | KPTI Stock News
StockTitan53 · neutralproduct/pr
Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026
PR Newswire50 · neutralproduct/pr
Karyopharm Therapeutics Inc. (KPTI) Discusses Phase III SENTRY Trial Results of Selinexor Plus Ruxolitinib in Myelofibrosis Transcript
Seeking Alpha58 · neutralproduct/pr
Karyopharm Therapeutics Inc. (KPTI) Discusses Phase III SENTRY Trial Results of Selinexor Plus Ruxolitinib in Myelofibrosis - Slideshow
Seeking Alpha58 · neutralproduct/pr
Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | KPTI Stock News
StockTitan50 · neutralgeneral
Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire50 · neutralgeneral
Karyopharm Expands Equity Incentives and Launches PSU Program
TipRanks58 · neutralproduct/pr
Karyopharm to Participate at the 2026 Jefferies Global Healthcare Conference
PR Newswire53 · neutralproduct/pr
Karyopharm (KPTI) Leans on SENTRY in Pivotal Call
TipRanks58 · neutralearnings
Karyopharm Therapeutics Q1 Earnings Call Highlights
Yahoo Top67 · bullishearnings
Karyopharm Therapeutics GAAP EPS of -$1.24 beats by $0.25, revenue of $35.07M beats by $3.67M
Seeking Alpha68 · bullishearnings
Karyopharm to Participate at Upcoming Investor Conferences
PR Newswire50 · neutralgeneral
Karyopharm to Report First Quarter 2026 Financial Results on May 14, 2026
PR Newswire50 · neutralearnings